Efficient Generation of Large-Fragment Knock-In Mouse Models Using 2-Cell (2C)-Homologous Recombination (HR)-CRISPR
© 2020 John Wiley & Sons, Inc..
Generating large-fragment knock-ins, such as reporters, conditional alleles, or humanized alleles, directly in mouse embryos is still a challenging feat. We have developed 2C-HR-CRISPR, a technology that allows highly efficient (10-50%) and rapid (generating founders in 2 months) targeting of large DNA fragments. Key to this strategy is the delivery of CRISPR reagents into 2-cell-stage mouse embryos, taking advantage of the high homologous recombination activity during the long G2 cell cycle phase at this stage. Furthermore, by exploiting a Cas9-monomeric streptavidin (Cas-mSA) and biotinylated PCR template (BioPCR) system to localize the repair template to specific double strand breaks, the efficiency can be further improved to up to 95%. Here we provide a procedure to generate large-fragment knock-in mouse models using 2C-HR-CRISPR. We first describe the principles for designing single guide RNAs and repair templates but refer to published manuscripts and protocols for molecular cloning methods or commercial sources for these reagents. We then describe two unique aspects of 2C-HR-CRISPR that are critical for success: (1) production of the CRISPR reagents for 2C-HR-CRISPR, particularly for applying the Cas9-mSA/BioPCR method, and (2) microinjection of mouse embryos at the 2-cell stage. © 2020 by John Wiley & Sons, Inc. Basic Protocol 1: Single guide RNA and repair template design Basic Protocol 2: Preparing reagents for 2C-HR-CRISPR Basic Protocol 3: Microinjecting 2-cell-stage mouse embryos.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:10 |
---|---|
Enthalten in: |
Current protocols in mouse biology - 10(2020), 1 vom: 21. März, Seite e67 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Gu, Bin [VerfasserIn] |
---|
Links: |
---|
Themen: |
2-cell embryos |
---|
Anmerkungen: |
Date Completed 29.09.2020 Date Revised 29.09.2020 published: Print Citation Status MEDLINE |
---|
doi: |
10.1002/cpmo.67 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM305123653 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM305123653 | ||
003 | DE-627 | ||
005 | 20231225120506.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1002/cpmo.67 |2 doi | |
028 | 5 | 2 | |a pubmed24n1017.xml |
035 | |a (DE-627)NLM305123653 | ||
035 | |a (NLM)31912993 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Gu, Bin |e verfasserin |4 aut | |
245 | 1 | 0 | |a Efficient Generation of Large-Fragment Knock-In Mouse Models Using 2-Cell (2C)-Homologous Recombination (HR)-CRISPR |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 29.09.2020 | ||
500 | |a Date Revised 29.09.2020 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2020 John Wiley & Sons, Inc. | ||
520 | |a Generating large-fragment knock-ins, such as reporters, conditional alleles, or humanized alleles, directly in mouse embryos is still a challenging feat. We have developed 2C-HR-CRISPR, a technology that allows highly efficient (10-50%) and rapid (generating founders in 2 months) targeting of large DNA fragments. Key to this strategy is the delivery of CRISPR reagents into 2-cell-stage mouse embryos, taking advantage of the high homologous recombination activity during the long G2 cell cycle phase at this stage. Furthermore, by exploiting a Cas9-monomeric streptavidin (Cas-mSA) and biotinylated PCR template (BioPCR) system to localize the repair template to specific double strand breaks, the efficiency can be further improved to up to 95%. Here we provide a procedure to generate large-fragment knock-in mouse models using 2C-HR-CRISPR. We first describe the principles for designing single guide RNAs and repair templates but refer to published manuscripts and protocols for molecular cloning methods or commercial sources for these reagents. We then describe two unique aspects of 2C-HR-CRISPR that are critical for success: (1) production of the CRISPR reagents for 2C-HR-CRISPR, particularly for applying the Cas9-mSA/BioPCR method, and (2) microinjection of mouse embryos at the 2-cell stage. © 2020 by John Wiley & Sons, Inc. Basic Protocol 1: Single guide RNA and repair template design Basic Protocol 2: Preparing reagents for 2C-HR-CRISPR Basic Protocol 3: Microinjecting 2-cell-stage mouse embryos | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a 2-cell embryos | |
650 | 4 | |a CRISPR-Cas9 | |
650 | 4 | |a conditional allele | |
650 | 4 | |a genome editing | |
650 | 4 | |a homologous recombination | |
650 | 4 | |a humanization | |
650 | 4 | |a large fragment knock-in | |
650 | 4 | |a microinjection | |
650 | 4 | |a reporter | |
700 | 1 | |a Posfai, Eszter |e verfasserin |4 aut | |
700 | 1 | |a Gertsenstein, Marina |e verfasserin |4 aut | |
700 | 1 | |a Rossant, Janet |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Current protocols in mouse biology |d 2011 |g 10(2020), 1 vom: 21. März, Seite e67 |w (DE-627)NLM209288434 |x 2161-2617 |7 nnns |
773 | 1 | 8 | |g volume:10 |g year:2020 |g number:1 |g day:21 |g month:03 |g pages:e67 |
856 | 4 | 0 | |u http://dx.doi.org/10.1002/cpmo.67 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 10 |j 2020 |e 1 |b 21 |c 03 |h e67 |